Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06174779
PHASE3

A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

Sponsor: Hanmi Pharmaceutical Company Limited

View on ClinicalTrials.gov

Summary

A multicenter, randomized, double-blind, phase 3 study to evaluate efficacy and safety of HM11260C in adult obesity patients without diabetes mellitus

Official title: A Multicenter, Randomized, Double-blind, Phase 3 Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

420

Start Date

2024-01-03

Completion Date

2026-07-31

Last Updated

2025-06-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

HM11260C

Test drug

DRUG

Placebo

Placebo drug

Locations (1)

Kangbuk samsung hospital

Seoul, South Korea